Retatrutide 20mg Pen is High grade Purity tested. Alluvi Retatrutide is a triple agonist peptide studied for its activity on GLP-1, GIP, and glucagon receptors. It has been investigate for its potential role in weight management, glucose regulation, and metabolic health.

Key Features:

• Triple receptor agonist: GLP-1, GIP, and glucagon.
• Investigated for effects on appetite regulation, energy expenditure, and insulin sensitivity.
• Long-acting peptide designed for extended receptor activity.
• Stable in lyophilised form; easily reconstituted for research applications.

Retatrutide 20mg Pen Specifications:

• Form: Pen
• Unit Size: 20 mg
• Appearance: White/off-white solid
• Storage (unreconstituted): ≤ -20 °C, dark, dry
• Reconstitution: Sterile bacteriostatic water
• Stability (reconstituted): Store at 2–8 °C, short-term

Usage notice:

The Retatrutide 20mg Pen products offer on this website are furnish for in-vitro studies only. In-vitro studies are perform outside of the body. These products are not medicines or drugs and have not been approve to prevent, treat or cure any medical condition, ailment or disease. Bodily introduction of any kind into humans or animals is strictly forbidden, as outline in disclaimer of liability and terms of sale.